Complications from carcinoid syndrome: review of the current evidence
Carregando...
Citações na Scopus
61
Tipo de produção
article
Data de publicação
2016
Editora
CANCER INTELLIGENCE LTD
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
ECANCERMEDICALSCIENCE, v.10, article ID 662, 17p, 2016
Resumo
Patients with well-differentiated neuroendocrine tumours may develop carcinoid syndrome (CS), which is characterised by flushing, abdominal cramps, diarrhoea, and bronchospasms. In this scenario, long-term secretion of vasoactive substances-serotonin, tachynins, and others, may induce fibrogenic responses in local or distant tissues, leading to complications such as carcinoid heart disease (CHD), mesenteric and/or retroperitoneal fibrosis. Rare cases of lung/pleural fibrosis and scleroderma have also been described. Despite it not being well described yet, current evidence suggests the pathogenesis of such fibrogenic complications relies on signalling through 5-HT2B and TGF-beta 1. Medical management is still very limited and lacks prospective and randomised studies for definitive recommendations. Surgical procedures remain the best definitive treatment option for CHD and abdominal fibrosis. Recently, cognitive impairment has also been described as a potential consequence of CS. This review critically discusses the literature concerning the epidemiology, pathogenesis, clinical features, diagnosis, and treatment options for CS-related long-term complications.
Palavras-chave
carcinoid syndrome, complications, carcinoid heart disease, fibrosis
Referências
- Al Kharrat H, 2003, J CLIN GASTROENTEROL, V36, P87
- Becher G, 2013, CLIN EXP DERMATOL, V38, P310, DOI 10.1111/ced.12046
- Bell HK, 2005, BRIT J DERMATOL, V152, P71, DOI 10.1111/J.1365-2133.2004.06273.X
- Bergestuen DS, 2010, NEUROENDOCRINOLOGY, V92, P168, DOI 10.1159/000318014
- Bergestuen DS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-6
- Bernheim AM, 2008, MAYO CLIN PROC, V83, P143, DOI 10.4065/83.2.143
- Bernheim AM, 2007, PROG CARDIOVASC DIS, V49, P439, DOI 10.1016/j.pcad.2006.12.002
- Bernheim AM, 2007, AM J CARDIOL, V99, P292, DOI 10.1016/j.amjcard.2006.07.092
- BERRY EM, 1974, GUT, V15, P34, DOI 10.1136/gut.15.1.34
- Bhattacharyya S, 2011, AM J CARDIOL, V107, P1221, DOI 10.1016/j.amjcard.2010.12.025
- Bhattacharyya S, 2010, CIRC-CARDIOVASC IMAG, V3, P103, DOI 10.1161/CIRCIMAGING.109.886846
- Bhattacharyya S, 2008, AM J CARDIOL, V101, P378, DOI 10.1016/j.amjcard.2007.08.045
- Bhattacharyya S, 2009, LANCET, V374, P577, DOI 10.1016/S0140-6736(09)60252-X
- Bhattacharyya S, 2008, AM J CARDIOL, V102, P938, DOI 10.1016/j.amjcard.2008.05.047
- Bhattacharyya S, 2013, J HEART VALVE DIS, V22, P400
- Biasco E, 2015, TUMORI, V101, pE24, DOI 10.5301/tj.5000259
- BIVENS CH, 1973, NEW ENGL J MED, V289, P844, DOI 10.1056/NEJM197310182891608
- Borman RA, 1997, ANN NY ACAD SCI, V812, P224, DOI 10.1111/j.1749-6632.1997.tb48183.x
- Bouma G, 2016, NEUROENDOCRINOLOGY, V103, P489, DOI 10.1159/000440621
- Capurso G, 2012, BRIT J SURG, V99, P1480, DOI 10.1002/bjs.8842
- Carrilho-Ferreira P, 2013, CAN J CARDIOL, V29, DOI 10.1016/j.cjca.2012.09.015
- Carter CA, 2015, CASE REP ONCOL, V8, P423, DOI 10.1159/000441122
- CASTIELLO RJ, 1972, ARCH DERMATOL, V105, P574, DOI 10.1001/archderm.105.4.574
- Castillo JG, 2008, BRIT J ANAESTH, V101, P618, DOI 10.1093/bja/aen237
- Castillo Javier G, 2013, Semin Cardiothorac Vasc Anesth, V17, P212, DOI 10.1177/1089253212465475
- Chambers AJ, 2010, WORLD J SURG, V34, P1356, DOI 10.1007/s00268-010-0404-9
- Chua Chiaco JM, 2013, CLEV CLIN J MED, V80, P638
- Condron ME, 2016, SURGERY, V159, P358, DOI 10.1016/j.surg.2015.05.036
- Connolly HM, 2015, J AM COLL CARDIOL, V66, P2189, DOI 10.1016/j.jacc.2015.09.014
- Connolly HM, 2002, CIRCULATION, V106, pI51, DOI 10.1161/01.cir.0000032884.55215.87
- CONNOLLY HM, 1995, J AM COLL CARDIOL, V25, P410, DOI 10.1016/0735-1097(94)00374-Y
- Denney WD, 1998, J AM COLL CARDIOL, V32, P1017, DOI 10.1016/S0735-1097(98)00354-4
- Dobson R, 2014, BRIT J CANCER, V111, P1703, DOI 10.1038/bjc.2014.468
- Dobson R, 2014, INT J CARDIOL, V173, P29, DOI 10.1016/j.ijcard.2014.02.037
- Dobson R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073679
- DONOWITZ M, 1975, AM J DIG DIS, V20, P1115, DOI 10.1007/BF01070754
- Druce MR, 2010, QJM-INT J MED, V103, P177, DOI 10.1093/qjmed/hcp191
- Druce M, 2009, NAT REV ENDOCRINOL, V5, P276, DOI 10.1038/nrendo.2009.51
- Edwards NC, 2016, J CLIN ENDOCR METAB, V101, P182, DOI 10.1210/jc.2015-3295
- ENGELMAN K, 1967, NEW ENGL J MED, V277, P1103, DOI 10.1056/NEJM196711232772101
- Fabre A, 2008, EUR RESPIR J, V32, P426, DOI 10.1183/09031936.00126907
- Franzen D, 2009, CLIN CARDIOL, V32, P92, DOI [10.1002/clc.20260, DOI 10.1002/CLC.20260]
- Gelhorn HL, 2016, CLIN THER, V38, P759, DOI 10.1016/j.clinthera.2016.03.002
- Gershon MD, 2013, CURR OPIN ENDOCRINOL, V20, P14, DOI 10.1097/MED.0b013e32835bc703
- Grozinsky-Glasberg S, 2015, NEUROENDOCRINOLOGY, V101, P263, DOI 10.1159/000381930
- Guo LJ, 2014, ASIAN PAC J CANCER P, V15, P6679, DOI 10.7314/APJCP.2014.15.16.6679
- GUPTA A, 1985, Q J MED, V56, P367
- Gustafsson BI, 2008, INT J CARDIOL, V129, P318, DOI 10.1016/j.ijcard.2008.02.019
- Gustafsson BI, 2005, CIRCULATION, V111, P1517, DOI 10.1161/01.CIR.0000159356.42064.48
- Hafizi S, 2000, J HEART VALVE DIS, V9, P454
- HARGREAVES AD, 1994, INT J CARDIOL, V45, P150, DOI 10.1016/0167-5273(94)90274-7
- HARRIS AL, 1983, CANCER CHEMOTH PHARM, V10, P137, DOI 10.1007/BF00446228
- Hellman P, 2002, WORLD J SURG, V26, P991, DOI 10.1007/s00268-002-6630-z
- Hemminki K, 2001, CANCER, V92, P2204, DOI 10.1002/1097-0142(20011015)92:8<2204::AID-CNCR1564>3.0.CO;2-R
- HIMELMAN RB, 1989, AM J CARDIOL, V63, P347, DOI 10.1016/0002-9149(89)90344-5
- Hutcheson JD, 2011, PHARMACOL THERAPEUT, V132, P146, DOI 10.1016/j.pharmthera.2011.03.008
- Jackson LN, 2009, CLIN CANCER RES, V15, P2747, DOI 10.1158/1078-0432.CCR-08-2346
- JACOBSEN MB, 1995, EUR HEART J, V16, P263
- Janssen W, 2015, BIOMED RES INT, DOI 10.1155/2015/438403
- Jian B, 2002, AM J PATHOL, V161, P2111, DOI 10.1016/S0002-9440(10)64489-6
- KAHIL ME, 1964, ARCH INTERN MED, V114, P26
- Koopmans KP, 2005, J NUCL MED, V46, P1240
- KUCUK O, 1988, CANCER, V62, P1026, DOI 10.1002/1097-0142(19880901)62:5<1026::AID-CNCR2820620532>3.0.CO;2-E
- Kulke MH, 2015, EUR J CANCER, V51, pS728
- Kulke MH, 2015, NANETS S
- KVOLS LK, 1994, ANN NY ACAD SCI, V733, P464, DOI 10.1111/j.1749-6632.1994.tb17296.x
- KVOLS LK, 1985, NEW ENGL J MED, V313, P1229
- Lafaras CT, 2010, ONKOLOGIE, V33, P300, DOI 10.1159/000313596
- Lillegard JB, 2011, J AM COLL SURGEONS, V213, P130, DOI 10.1016/j.jamcollsurg.2011.03.029
- Makridis C, 1996, WORLD J SURG, V20, P900
- Mansencal N, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2006.02.019
- Mansencal N, 2010, AM J CARDIOL, V105, P527, DOI 10.1016/j.amjcard.2009.10.023
- Mansencal N, 2008, AM J CARDIOL, V101, P1035, DOI 10.1016/j.amjcard.2007.11.056
- Massimino K, 2013, J SURG ONCOL, V107, P842, DOI 10.1002/jso.23323
- MILLER RR, 1995, AM J SURG PATHOL, V19, P653, DOI 10.1097/00000478-199506000-00005
- Modlin IM, 2004, AM J GASTROENTEROL, V99, P2466, DOI 10.1111/j.1572-0241.2004.40507.x
- Modlin IM, 2005, GASTROENTEROLOGY, V128, P1717, DOI 10.1053/j.gastro.2005.03.038
- Mokhles P, 2012, EUR J CARDIO-THORAC, V41, P1278, DOI 10.1093/ejcts/ezr227
- Moller JE, 2003, NEW ENGL J MED, V348, P1005, DOI 10.1056/NEJMoa021451
- Moller JE, 2005, CIRCULATION, V112, P3320, DOI 10.1161/CIRCULATIONAHA.105.553750
- MONERETVAUTRIN DA, 1993, BRIT J ANAESTH, V71, P609, DOI 10.1093/bja/71.4.609
- MORGAN JG, 1974, ANN SURG, V180, P720, DOI 10.1097/00000658-197411000-00003
- Morrisroe K, 2012, INTERN MED J, V42, P342, DOI 10.1111/j.1445-5994.2012.02719.x
- MOSS SF, 1993, Q J MED, V86, P49
- Musunuru S, 2005, J SURG RES, V126, P102, DOI 10.1016/j.jss.2005.01.003
- Nebigil CG, 2003, CIRCULATION, V107, P3223, DOI 10.1161/01.CIR.0000074224.57016.01
- Nebigil CG, 2000, P NATL ACAD SCI USA, V97, P9508, DOI 10.1073/pnas.97.17.9508
- OATES JA, 1964, LANCET, V1, P514
- OHRI SK, 1994, ANN THORAC SURG, V58, P1161
- Pape UF, 2012, NEUROENDOCRINOLOGY, V95, P135, DOI 10.1159/000335629
- Pasieka JL, 2014, ANN SURG, V259, P355, DOI 10.1097/SLA.0b013e318288ff6d
- Patel C, 2014, AM HEART J, V167, P789, DOI 10.1016/j.ahj.2014.03.018
- Pavel ME, 2011, LANCET, V378, P2005, DOI 10.1016/S0140-6736(11)61742-X
- PELLIKKA PA, 1993, CIRCULATION, V87, P1188
- PETRIK PK, 1989, AM J FOREN MED PATH, V10, P146, DOI 10.1097/00000433-198906000-00011
- Plockinger U, 2009, NEUROENDOCRINOLOGY, V90, P190, DOI 10.1159/000225947
- Propst J W, 1994, J Cardiothorac Vasc Anesth, V8, P209, DOI 10.1016/1053-0770(94)90065-5
- Rajamannan NM, 2001, J HEART VALVE DIS, V10, P827
- RATNAVEL RC, 1994, CLIN EXP DERMATOL, V19, P83, DOI 10.1111/j.1365-2230.1994.tb01126.x
- RIDKER PM, 1991, AM HEART J, V121, P1835, DOI 10.1016/0002-8703(91)90045-J
- Rinke A, 2009, J CLIN ONCOL, V27, P4656, DOI 10.1200/JCO.2009.22.8510
- Rinke A, 2017, NEUROENDOCRINOLOGY, V104, P26
- ROBIOLIO PA, 1995, CIRCULATION, V92, P790
- ROBIOLIO PA, 1995, AM J CARDIOL, V75, P485, DOI 10.1016/S0002-9149(99)80586-4
- Russo S, 2004, PSYCHOSOM MED, V66, P422, DOI 10.1097/01.psy.0000126204.97565.91
- Sakai D, 2000, PATHOL INT, V50, P404, DOI 10.1046/j.1440-1827.2000.01053.x
- Shah GM, 2005, AM J GASTROENTEROL, V100, P2307, DOI 10.1111/j.1572-0241.2005.00268.x
- Simula DV, 2002, MAYO CLIN PROC, V77, P139
- Soga J, 1999, J EXP CLIN CANC RES, V18, P133
- Soga J, 2003, J EXP CLIN CANC RES, V22, P517
- SWAIN CP, 1976, GASTROENTEROLOGY, V71, P484
- Tamagno G, 2007, INTERNAL MED, V46, P425, DOI 10.2169/internalmedicine.46.6367
- THORBURN CW, 1983, AM J CARDIOL, V51, P1128, DOI 10.1016/0002-9149(83)90357-0
- VINIK AI, 1989, GASTROENTEROL CLIN N, V18, P865
- Walsh JS, 2013, J CLIN ENDOCR METAB, V98, P2902, DOI 10.1210/jc.2012-4174
- WALTENBERGER J, 1993, AM J PATHOL, V142, P71
- Weingarten TN, 2007, ANESTH ANALG, V105, P1192, DOI 10.1213/01.ane.0000284704.57806.0b
- Westberg G, 2001, BRIT J SURG, V88, P865, DOI 10.1046/j.0007-1323.2001.01798.x
- Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377
- Zacks J, 2016, 13 ANN ENETS C
- ZARAFONETIS CJD, 1958, AM J MED SCI, V236, P1, DOI 10.1097/00000441-195807000-00001
- Zuetenhorst J, 2004, BRIT J CANCER, V90, P2073, DOI 10.1038/sj.bjc.6601816
- Zuetenhorst JM, 2003, CANCER, V97, P1609, DOI 10.1002/cncr.11226